Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, October 1 '25)

Image
By G.M.

 


    Arch Virol

  1. YIN Y, Chen J, Chen S, Huang J, et al
    The SARS-CoV-2 N protein disrupts G3BP1 function and alters lipid metabolism in COVID-19 pathogenesis.
    Arch Virol. 2025;170:237.
    PubMed         Abstract available


    Biochem Soc Trans

  2. CALL MJ, Call ME, Wu X
    Insights from deep mutational scanning in the context of an emerging pathogen.
    Biochem Soc Trans. 2025;53:1169-1179.
    PubMed         Abstract available


    BMC Pediatr

  3. VASQUEZ-LOARTE T, Guerra GA, Saldarriaga EM, Torres-Gomez L, et al
    Healthcare access satisfaction before and during the COVID-19 pandemic among Peruvian children with down syndrome.
    BMC Pediatr. 2025;25:874.
    PubMed         Abstract available


    Drugs

  4. SYED YY
    Clesrovimab: First Approval.
    Drugs. 2025;85:1487-1492.
    PubMed         Abstract available


    J Exp Med

  5. BISSETT C, Yong L, Spencer AJ, Ma FNL, et al
    Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms.
    J Exp Med. 2026;223:e20241529.
    PubMed         Abstract available


    J Immunol

  6. DEVITO L, Mohanraj OS, Debnath D, Constantinesco NJ, et al
    Influenza infection exacerbates high-fat diet-induced atherosclerosis in apolipoprotein gene-deficient mice.
    J Immunol. 2025 Oct 30:vkaf276. doi: 10.1093.
    PubMed         Abstract available

  7. SILVA-MORAES V, Reis LR, Ross TM
    Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.
    J Immunol. 2025 Oct 30:vkaf286. doi: 10.1093.
    PubMed         Abstract available

  8. BRADLEY MC, Aliyu T, Gray J, Guan T, et al
    Dietary iron deficiency impairs effector function of memory T cells following influenza infection.
    J Immunol. 2025 Oct 29:vkaf291. doi: 10.1093.
    PubMed         Abstract available


    J Infect Dis

  9. XU Y, Li M, Peng L, Wang C, et al
    Comparative Analysis of Flight Volume Effects on COVID-19 and Influenza Transmission Across Variable Control Intensities, 2019-2024.
    J Infect Dis. 2025 Oct 27:jiaf545. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  10. LEI H, Xiao B, Lin X, Liang Z, et al
    Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002.
    J Virol. 2025 Oct 31:e0132925. doi: 10.1128/jvi.01329.
    PubMed         Abstract available


    J Virol Methods

  11. MAHMOOD S, Thomas SS, Ross CS, Fothergill L, et al
    Understanding limitations to successful avian influenza virus isolation from wild birds.
    J Virol Methods. 2025 Oct 26:115291. doi: 10.1016/j.jviromet.2025.115291.
    PubMed         Abstract available


    JAMA

  12. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed         Abstract available

  13. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    PubMed         Abstract available


    N Engl J Med

  14. SCOTT J, Abers MS, Marwah HK, McCann NC, et al
    Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
    N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMsa2514268.
    PubMed         Abstract available


    Pediatrics

  15. WOOLF SH
    The Youth Mental Health Crisis in the United States: Epidemiology, Contributors, and Potential Solutions.
    Pediatrics. 2025;156:e2025070849.
    PubMed         Abstract available

  16. CASTILLO FB, Muniz E, Silver EJ, Benenson B, et al
    School Disengagement Among Children With Mental Health Conditions Pre- and Intra-COVID-19 Pandemic.
    Pediatrics. 2025;156:e2024068387.
    PubMed         Abstract available


    PLoS Comput Biol

  17. LIN Y, Hay JA, Meng Y, Cowling BJ, et al
    Generalizing population RT-qPCR cycle threshold values-informed estimation of epidemiological dynamics: Impact of surveillance practices and pathogen variability.
    PLoS Comput Biol. 2025;21:e1013527.
    PubMed         Abstract available


    PLoS One

  18. KOLIVAND P, Arabloo J, Saberian P, Dorooudi T, et al
    Health systems performance in health outcomes, health financing and COVID-19 pandemic: Lessons from 31 countries.
    PLoS One. 2025;20:e0334693.
    PubMed         Abstract available

  19. KONOMI F, Bino S, Mersini K, Ramaj A, et al
    COVID-19 breakthrough infections during the circulation of Delta and Omicron variants in Tirana, Albania, April 2021-March 2022.
    PLoS One. 2025;20:e0335197.
    PubMed         Abstract available

  20. FORTIN A, Huot S, Caron E, Laflamme C, et al
    No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo.
    PLoS One. 2025;20:e0332261.
    PubMed         Abstract available

  21. MELANDER S, Enlund G, Engstrand Lilja H, Frykholm P, et al
    The Covid-19 pandemic in Sweden: Prolonged and unevenly distributed effects on the volume of pediatric anesthesia and surgery demonstrated by data from the Swedish Perioperative Register.
    PLoS One. 2025;20:e0335400.
    PubMed         Abstract available

  22. MACURA M, Todorovic J, Pavlovic V, Ivanovic K, et al
    First Balkan Brief Illness Perception Questionnaire (IPQ-B) among high-risk pregnancies.
    PLoS One. 2025;20:e0334844.
    PubMed         Abstract available

  23. ROCKENFELLER R, Gunther M
    Cohort-resolved excess mortality in Germany (2000-2024): Patterns and implications for the SARS-CoV-2 era.
    PLoS One. 2025;20:e0334884.
    PubMed         Abstract available

  24. AMBRASE A, Hendrickx M, Grahlow M, Wong HY, et al
    The German translation of the Oxford utilitarianism scale: Validation and the impact of the Covid-19 pandemic on the observations.
    PLoS One. 2025;20:e0335215.
    PubMed         Abstract available

  25. KHASAWNEH R, Bartlow AW, Almharat S, Almuhasen A, et al
    Sequencing and analysis of 131 SARS-CoV-2 isolates in previously sampled and unsampled regions of Jordan from 2020 to 2023.
    PLoS One. 2025;20:e0335070.
    PubMed         Abstract available

  26. RAJENDRAM R, AlShamrani AA, Alqaraishi AM
    Associations between day of admission, admission hyponatremia and hospital outcomes in medical patients: A retrospective multicenter cohort study.
    PLoS One. 2025;20:e0335248.
    PubMed         Abstract available

  27. LIBERDA EN, Ahmed F, Spence ND, Plain S, et al
    Intersecting challenges and ways forward: The impact of the COVID-19 pandemic on an urban First Nations community in Southern Ontario, Canada.
    PLoS One. 2025;20:e0335020.
    PubMed         Abstract available

  28. ATILGAN E, Turkmen Ceylan FB, Doruk OT, Ertugrul HM, et al
    The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies.
    PLoS One. 2025;20:e0334970.
    PubMed         Abstract available

  29. CANNAC O, Pauly V, Zandotti C, Luciani L, et al
    Cytomegalovirus reactivation in mechanically ventilated patients with or without SARS-CoV-2 infection: A retrospective cohort study.
    PLoS One. 2025;20:e0328494.
    PubMed         Abstract available

  30. STEWART S, Kalra PA, Kontopantelis E, Blakeman T, et al
    Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death.
    PLoS One. 2025;20:e0333881.
    PubMed         Abstract available

  31. FERRER-URBINA R, Elgueta H, Carmona-Halty M, Sepulveda-Paez G, et al
    Epistemically unwarranted beliefs scale, development and evidence of validity in the Chilean population.
    PLoS One. 2025;20:e0333911.
    PubMed         Abstract available

  32. DURSTENFELD MS, Mataraarachchi N, Peluso MJ, Levkova-Clark M, et al
    Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing.
    PLoS One. 2025;20:e0335218.
    PubMed         Abstract available

  33. GRIMA AA, Hiraki LT, Bolotin S, Paterson AD, et al
    New onset autoimmune disease following a SARS-CoV-2 infection: A systematic review protocol.
    PLoS One. 2025;20:e0335766.
    PubMed         Abstract available

  34. WILSON D, Kardam N
    What do students expect from teaching assistants (TAs)? Considerations of gender, race, and international status.
    PLoS One. 2025;20:e0334904.
    PubMed         Abstract available

  35. NAKAMURA I, Koizumi Y, Araoka H, Hata H, et al
    Risk factors for aggravated COVID-19 despite medical care after admission among Japanese patients: A Japanese association for infectious diseases COVID registry study.
    PLoS One. 2025;20:e0335439.
    PubMed         Abstract available

  36. FLORES-DE-SANTIAGO F, Amezcua F, Rodriguez-Sobreyra R, Alvarez-Sanchez LF, et al
    Assessing COVID-19 lockdown effects on coastal water quality in a strongly impacted tourist destination using Sentinel-2 multispectral data.
    PLoS One. 2025;20:e0334974.
    PubMed         Abstract available

  37. ALMAKKY I, Yaqub M
    Weakly-supervised explainable infection severity classification from chest CT scans.
    PLoS One. 2025;20:e0334431.
    PubMed         Abstract available

  38. ADUA L, Ampofo K, Heller E, Gesteland P, et al
    Caregiver psychological burden of RSV Hospitalization of children 2 years of age and under.
    PLoS One. 2025;20:e0334405.
    PubMed         Abstract available

  39. LIEBL ME, Reisshauer A, Loudovici-Krug D, Baumbach P, et al
    Utilization of interdisciplinary in-hospital early rehabilitation in COVID-19 patients - a multicenter cohort study in the National Pandemic Cohort Network (NAPKON) in Germany.
    PLoS One. 2025;20:e0334941.
    PubMed         Abstract available

  40. SALEH E, Asar ME, Ghaneapur MR, Harati Asl N, et al
    Exploring the impact of COVID-19 pandemic on nurses: A cross-sectional study on job burnout and quality of work life.
    PLoS One. 2025;20:e0331247.
    PubMed         Abstract available

  41. MULHEM E, Zeman LL, Childers K, Roy S, et al
    Association of health behaviors with healthcare workers' physical and psychological well-being: Learning from the COVID-19 pandemic.
    PLoS One. 2025;20:e0334752.
    PubMed         Abstract available

  42. YE A, Mack M, Ice R, Heath T, et al
    One SQ HEDGES DNA vector only dose produces durable hGLA or anti-SARS-CoV-2 mAb therapeutic serum protein levels.
    PLoS One. 2025;20:e0315041.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  43. GIBSON GC, Fox SJ, Javan E, Ptak SE, et al
    Improving outbreak forecasts through model augmentation.
    Proc Natl Acad Sci U S A. 2025;122:e2508575122.
    PubMed         Abstract available

  44. POLYCARPOU A, Wagner-Gamble T, Greenlaw R, O'Neill L, et al
    Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells.
    Proc Natl Acad Sci U S A. 2025;122:e2521209122.
    PubMed         Abstract available


    Vaccine

  45. LOPEZ-ZAMBRANO MA, Sanchez-Gomez A, Lasheras Carbajo MD, Gutierrez Rodriguez MA, et al
    Trend and factors associated to pertussis and influenza vaccination in pregnant women in Madrid, Spain, 2018-2023 - a retrospective cohort study.
    Vaccine. 2025;68:127895.
    PubMed         Abstract available

  46. LI V, McClure H, Patel R, Kuchel GA, et al
    Medication count, including statin or metformin use, is not associated with influenza vaccine responses in older adults.
    Vaccine. 2025;68:127913.
    PubMed         Abstract available


    Virology

  47. JOHNSON MG, Strizki JM, Hilbert DW, Zhang Y, et al
    Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial.
    Virology. 2026;613:110710.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »